W. Chan

The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children

E. Lau, D. Hui, S. Valkenburg, 2021, medRxiv.

SARS-CoV-2 accessory proteins reveal distinct serological signatures in children

Abraham J. Qavi, E. Lau, S. Valkenburg, 2022, Nature Communications.

Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection

O. Tsang, E. Lau, M. Peiris, 2021, EClinicalMedicine.

Clinical Characteristics and Transmission of COVID-19 in Children and Youths During 3 Waves of Outbreaks in Hong Kong

P. Tam, K. To, K. Yuen, 2021, JAMA network open.